Search

everythinglearnresearchcommunity

for

Search:↓

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

3α‐OH‐DHP is essential for reducing nerve activity related to blood pressure control during pregnancy.

5α-reduced neurosteroids may help regulate glial cell differentiation.

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

Anagen grow may effectively treat hair loss by blocking testosterone and reducing enzyme activity.

GLP-1RA therapy may increase the risk of hair loss.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

Some curcumin-like compounds can effectively and safely block the enzyme linked to hair loss and other conditions related to male hormones.

AH-001 could be a safer and more effective treatment for hair loss.

Mutations in certain receptors can cause diseases and offer new treatment options.

The retinoid receptor antagonist effectively disrupts vitamin A-related development in embryos.

Newer retinoid drugs are effective for skin conditions but have significant side effects.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

New compounds show promise as nonsteroidal treatments for hair loss.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

New drugs like clonidine and prazosin show promise for treating high blood pressure despite some side effects.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

The new nasal gel for schizophrenia improved drug absorption and brain effects in rats.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Using minoxidil for hair growth may cause skin lesions in some people, and taking breaks from nitrate patches for angina might worsen symptoms.

Thyroid receptor β can help develop new drugs to treat hair loss.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

Nitrendipine and nifedipine effectively block muscle contractions, while papaverine relaxes them and minoxidil needs high amounts to work.